
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.980 | 3.980 | 0.000 |
Shares | 96.250 | 96.250 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.460 | 22.095 |
Price to Book | 2.168 | 3.137 |
Price to Sales | 1.319 | 2.113 |
Price to Cash Flow | 5.444 | 12.367 |
Dividend Yield | 0.236 | 0.646 |
5 Years Earnings Growth | 10.002 | 14.194 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 26.170 | 20.240 |
Technology | 24.340 | 23.938 |
Industrials | 18.520 | 20.315 |
Consumer Cyclical | 12.710 | 11.090 |
Financial Services | 6.660 | 10.118 |
Communication Services | 3.900 | 2.146 |
Energy | 2.520 | 3.609 |
Consumer Defensive | 2.470 | 4.589 |
Basic Materials | 1.620 | 3.337 |
Utilities | 1.090 | 1.452 |
Number of long holdings: 87
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ADMA Biologics Inc | US0008991046 | 5.29 | 17.9800 | -3.75% | |
Imax | CA45245E1097 | 2.57 | 24.00 | +0.84% | |
Primoris | US74164F1030 | 2.35 | 86.07 | -1.43% | |
Ultra Cleans | US90385V1070 | 2.21 | 25.06 | +1.95% | |
Cellebrite | IL0011794802 | 2.00 | 14.250 | -2.53% | |
Camtek | IL0010952641 | 1.97 | 30,170 | -1.08% | |
Blue Bird | US0953061068 | 1.96 | 42.86 | -0.97% | |
American Superconductor | US0301112076 | 1.94 | 40.96 | +0.61% | |
Catalyst Pharmaceuticals | US14888U1016 | 1.91 | 20.950 | -3.10% | |
GeneDx Holdings Corp Ordinary Shares - Class A | - | 1.84 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Oberweis International Opps Instl | 280.18M | 10.47 | -9.69 | 5.80 | ||
Oberweis International Opportunitie | 121.88M | 10.22 | -9.81 | 5.44 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review